rs185100172

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_030973.4(MED25):​c.1794C>T​(p.Ala598Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00757 in 1,608,894 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0050 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0078 ( 86 hom. )

Consequence

MED25
NM_030973.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.705

Publications

1 publications found
Variant links:
Genes affected
MED25 (HGNC:28845): (mediator complex subunit 25) This gene encodes a component of the transcriptional coactivator complex termed the Mediator complex. This complex is required for transcription of most RNA polymerase II-dependent genes. The encoded protein plays a role in chromatin modification and in preinitiation complex assembly. Mutations in this gene are associated with Charcot-Marie-Tooth disease type 2B2. [provided by RefSeq, Apr 2010]
MED25 Gene-Disease associations (from GenCC):
  • congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Charcot-Marie-Tooth disease type 2B2
    Inheritance: AR Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 19-49835774-C-T is Benign according to our data. Variant chr19-49835774-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 215536.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.705 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00504 (768/152284) while in subpopulation SAS AF = 0.019 (92/4832). AF 95% confidence interval is 0.0159. There are 3 homozygotes in GnomAd4. There are 392 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED25NM_030973.4 linkc.1794C>T p.Ala598Ala synonymous_variant Exon 16 of 18 ENST00000312865.10 NP_112235.2 Q71SY5-1
MED25NM_001378355.1 linkc.1794C>T p.Ala598Ala synonymous_variant Exon 16 of 18 NP_001365284.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED25ENST00000312865.10 linkc.1794C>T p.Ala598Ala synonymous_variant Exon 16 of 18 1 NM_030973.4 ENSP00000326767.5 Q71SY5-1

Frequencies

GnomAD3 genomes
AF:
0.00504
AC:
767
AN:
152166
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0188
Gnomad FIN
AF:
0.00423
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00710
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00716
AC:
1709
AN:
238760
AF XY:
0.00839
show subpopulations
Gnomad AFR exome
AF:
0.00143
Gnomad AMR exome
AF:
0.00345
Gnomad ASJ exome
AF:
0.00339
Gnomad EAS exome
AF:
0.000388
Gnomad FIN exome
AF:
0.00549
Gnomad NFE exome
AF:
0.00683
Gnomad OTH exome
AF:
0.00687
GnomAD4 exome
AF:
0.00783
AC:
11405
AN:
1456610
Hom.:
86
Cov.:
32
AF XY:
0.00827
AC XY:
5991
AN XY:
724664
show subpopulations
African (AFR)
AF:
0.00144
AC:
48
AN:
33398
American (AMR)
AF:
0.00367
AC:
164
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
0.00330
AC:
86
AN:
26072
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39606
South Asian (SAS)
AF:
0.0217
AC:
1867
AN:
86010
European-Finnish (FIN)
AF:
0.00522
AC:
271
AN:
51918
Middle Eastern (MID)
AF:
0.00695
AC:
40
AN:
5756
European-Non Finnish (NFE)
AF:
0.00764
AC:
8478
AN:
1109062
Other (OTH)
AF:
0.00742
AC:
446
AN:
60146
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
681
1362
2044
2725
3406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00504
AC:
768
AN:
152284
Hom.:
3
Cov.:
33
AF XY:
0.00526
AC XY:
392
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41566
American (AMR)
AF:
0.00359
AC:
55
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3470
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5176
South Asian (SAS)
AF:
0.0190
AC:
92
AN:
4832
European-Finnish (FIN)
AF:
0.00423
AC:
45
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00710
AC:
483
AN:
67982
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
45
89
134
178
223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00570
Hom.:
1
Bravo
AF:
0.00470
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 24, 2015
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 2 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome Benign:1
Nov 09, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
6.6
DANN
Benign
0.46
PhyloP100
-0.70
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs185100172; hg19: chr19-50339031; API